Cadvis Biotechnology
Wuhan
About Cadvis Biotechnology
Cadvis Biotechnology focuses on diagnostic reagents, revolutionary biological therapeutics, and technology research and services, including early prevention, early screening, early diagnosis, intraoperative auxiliary diagnosis, and treatment of tumor disorders, particularly gynecological cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $27.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2024)
- Website: whkdws.comsy
- Phone: +86 027-50187586
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Pharmaceutical
Canonical: https://fsome.com/organization/cadvis-biotechnology-148735 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.